FdaApplication
ANDA 218061
Identifiers
- fda_app_no: ANDA218061
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2025-06-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CETRORELIX ACETATE | CETRORELIX ACETATE | EQ 0.25MG BASE/VIAL | POWDER;SUBCUTANEOUS |
1 product